Efficacy and Safety of Olmertasan in elderly patients with mild to moderate hypertension

Trial Profile

Efficacy and Safety of Olmertasan in elderly patients with mild to moderate hypertension

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Olmesartan medoxomil; Ramipril
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms ESPORT
  • Most Recent Events

    • 08 Sep 2010 An open-label follow-on study will continue on from the 12-week randomisation portion of this trial, as reported in Journal of hypertension.
    • 08 Sep 2010 Full results were presentd in an article in the Journal of Hypertension.
    • 21 Jun 2010 Results presented at the 20th European Meeting on Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top